Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.130, Iss.2, 2004-02, pp. : 59-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

By Tanaka Shinji Arii Shigeki

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 235-241

Springer Publishing Company

Access to resources Recommend Favorite

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

By Arii Shigeki

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 234-234

Springer Publishing Company

Access to resources Recommend Favorite

Chronic Myelogenous Leukemia

Current Cancer Therapy Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

By Kudo Masatoshi

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 242-255

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Imatinib in the Treatment of Chronic Myelogenous Leukemia

By Dax Kurbegov Hagop M. Kantarjian Moshe Talpaz

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 337-348

Adis International

Access to resources Recommend Favorite